LifeMD (LFMD) News Today

LifeMD, Inc. (NASDAQ: LFMD) shares fell today after the company reported Q1 results and issued near‑term revenue guidance that came in below Street expectations. Volume was above average as investors reacted to an EPS miss, a weaker Q2 revenue outlook, and mixed underlying operating metrics (revenue beat and margin improvement).

• Positive Sentiment: Q1 revenue beat estimates and gross margin expanded ~420 basis points to ~88%, driven by a favorable revenue mix and lower fulfillment costs — this supports higher revenue quality even as profitability remains pressured. GlobeNewswire: Q1 2026 Results
• Positive Sentiment: Adjusted EBITDA loss (~$4.5M) was in line with the company’s guidance, indicating management’s cost control is tracking to plan. GlobeNewswire: Q1 2026 Results
• Positive Sentiment: Several brokerages still carry a favorable view (consensus rated “Moderate Buy”), which may cap downside if the company executes on margin and revenue mix improvements. AmericanBankingNews: Broker Consensus
• Neutral Sentiment: Management held an earnings call and made the transcript available — useful for details on customer metrics, cadence, and product trends but no immediate market‑moving surprises were highlighted in published excerpts. Seeking Alpha: Q1 2026 Earnings Call Transcript
• Negative Sentiment: Q1 EPS of ($0.20) missed consensus (loss of $0.14), a larger-than-expected earnings shortfall that likely triggered the selloff. Zacks: Q1 Results
• Negative Sentiment: Q2 revenue guidance of $47.0M–$50.0M materially misses the consensus (~$53.5M), signaling weaker near‑term top‑line momentum and pressuring the stock. MarketBeat: Q1 Release & Guidance
• Negative Sentiment: Management did not provide explicit EPS guidance for Q2/FY (EPS field empty in guidance), increasing near‑term uncertainty about profitability trajectory. MarketBeat: Guidance Details

Bottom line for investors: revenue strength and improved margins are positives, but the EPS miss, a soft Q2 revenue guide and the omission of EPS guidance increased uncertainty and likely drove the share decline today. Monitor management commentary from the call for customer/marketing cadence and any follow‑up guidance updates.